Go to content
UR Home

Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report

URN to cite this document:
urn:nbn:de:bvb:355-epub-439790
DOI to cite this document:
10.5283/epub.43979
Harrer, Dennis Christoph ; Menhart, Karin ; Mayer, Stephanie ; Herr, Wolfgang ; Reichle, Albrecht ; Vogelhuber, Martin
[img]
Preview
License: Creative Commons Attribution 4.0
PDF - Published Version
(892kB)
Date of publication of this fulltext: 02 Nov 2020 11:57


Abstract

Anaplastic large cell lymphoma (ALCL) with ALK-translocation constitutes an aggressive lymphoma with high sensitivity to anthracycline-based chemotherapy. Relapse, however, is observed in about one-third of patients. Salvage treatment incorporates high-dose chemotherapy followed by autologous or allogeneic stem cell transplantation, treatment with the CD30-specific immunoconjugate Brentuximab ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons